Electrochemical and structural characterisation of zirconia reinforced hydroxyapatite bioceramic sol–gel coatings on surgical grade 316L SS for biomedical applications

Abstract Yttria-stabilized zirconia (YSZ)/hydroxyapatite (HAP) composite coatings on surgical grade 316L stainless steel was carried out using sol–gel dip coating and calcination process. Various molar ratios of HAP and YSZ was developed, each YSZ/HAP gel coating showed an average particle size of ∼30 nm and the coatings were dried and calcined for crystallization. The functional group and crystallization characteristics of the coatings were analyzed using (FT-IR), X-ray diffraction (XRD) and energy dispersion X-ray analysis (EDXA). The formation of β-tricalcium phosphate (β-TCP) was controlled changing the Ca/P ratio in HAP phase and also YSZ content in the composite coatings. It was revealed that TCP content showed a very minimum value at Ca/P ratio of ∼1.67 and at YSZ content of 30 vol.%, respectively. The mechanism of increased β-TCP content with Ca/P ratio lower than 1.67 and increased YSZ content was explained as Ca-deficiency due to the Ca-diffusion into t-ZrO 2 crystals to form a solid solution. The resultant coatings were analysed for its corrosion resistance through polarisation, impedance and ICP-AES analysis in simulated body fluid. The viability of the reinforced coatings were analysed by in vitro cell culture studies.

[1]  P Ducheyne,et al.  Bioactive ceramics: the effect of surface reactivity on bone formation and bone cell function. , 1999, Biomaterials.

[2]  A. Rapacz-Kmita,et al.  Phase stability of hydroxyapatite–zirconia (HAp–ZrO2) composites for bone replacement , 2004 .

[3]  K. Niihara,et al.  Dense Hydroxyapatite–Zirconia Ceramic Composites with High Strength for Biological Applications , 2001 .

[4]  R. Domingues,et al.  Microstructural and mechanical study of zirconia-hydroxyapatite (ZH) composite ceramics for biomedical applications , 2001 .

[5]  R. R. Rao,et al.  Synthesis and sintering of hydroxyapatite–zirconia composites , 2002 .

[6]  V. V. Silva,et al.  Biological reactivity of zirconia-hydroxyapatite composites. , 2002, Journal of Biomedical Materials Research.

[7]  L. Hermansson,et al.  High-strength biofunctional zirconia: mechanical properties and static fatigue behaviour of zirconia-apatite composites , 1993 .

[8]  E. Adolfsson,et al.  Phase Analysis and Thermal Stability of Hot Isostatically Pressed Zirconia–Hydroxyapatite Composites , 2004 .

[9]  T. Matsuno,et al.  Microstructure and mechanical properties of sintered body of zirconia coated hydroxyapatite particles , 2000 .

[10]  R. Heimann,et al.  Effect of CaO on thermal decomposition during sintering of composite hydroxyapatite-zirconia mixtures for monolithic bioceramic implants , 1997 .

[11]  A. Mikos,et al.  Osteoblast function on synthetic biodegradable polymers. , 1994, Journal of biomedical materials research.

[12]  Larry L. Hench,et al.  Bioceramics: From Concept to Clinic , 1991 .

[13]  K. Khor,et al.  Yttria stabilized zirconia reinforced hydroxyapatite coatings , 2000 .

[14]  P. Andrew,et al.  Sensitivities of Human Monocytes and Epithelial Cells to Pneumolysin Are Different , 2002, Infection and Immunity.

[15]  A. Rapacz-Kmita,et al.  Evaluation of HAp-ZrO2 composites and monophase HAp bioceramics. In vitro study , 2004 .

[16]  T. Matsuno,et al.  THE SURFACE CHARACTERISTICS OF THE SINTERED BODY OF HYDROXYAPATITE-ZIRCONIA COMPOSITE PARTICLES , 1997 .

[17]  S. Rajeswari,et al.  Electrochemical characterization of hydroxyapatite coatings on HNO3 passivated 316L SS for implant applications , 2005 .